Category Pharmaceuticals
Mind the Ethical Gap in AI-Powered Drug Discovery
Dessislava Fessenko shows that while artificial intelligence might revolutionize drug development, its use comes with risks and potential ethical implications. Iterative ethics oversight from the get-go is needed to address the looming concerns.
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Whose Responsibility Are Ethical Issues in Phase 1 Research?
Dessislava Fessenko reveals that ethical concerns surrounding the participation of healthy volunteers in Phase 1 clinical trials have deep roots in broader social conditions, which require social policy responses.
A real prisoner’s dilemma: Organ donation for reduced sentences
Niklas Kirchner and Daniel Lucas identify three major moral problems with a recently proposed bill offering prisoners reduced sentences in exchange for organ donation.
Vaccine Skepticism is Becoming Irrelevant
Chris Kaposy acknowledges the ethical justification for coercive COVID-19 vaccine policies, while also recognizing the danger of ceasing to view vaccine skeptics as thinking subjects.
Impact Ethics 